Related Experiment Video
Updated: Feb 26, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer
Barbara S Taylor1, Kaku So-Armah, Janet P Tate
1*Medical Service/Infectious Diseases, South Texas Veterans Health Care System, San Antonio, TX; Department of Medicine, UT Health San Antonio, San Antonio, TX;†Department of Medicine, Boston University School of Medicine, Boston, MA;‡Section of General Internal Medicine, VA Connecticut Healthcare System, West Haven, CT; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT;§Medical Service, VA Medical Center, Atlanta, GA; Medical Service, Emory University School of Medicine, Atlanta, GA;‖Departments of Medicine and Biostatistics, Vanderbilt University School of Medicine, Nashville, TN;¶Department of Medicine, Infectious Diseases Section, VA North Texas Health Care System; UT Southwestern Medical Center, Dallas, TX;#Center for Health Equity Research and Promotion, VA Pittsburg Healthcare System, Pittsburgh, PA; Hamad Healthcare Quality Institute, Hamad Medical Corporation, Doha, Qatar; Department of Medicine, Weill Cornell Medical College, Doha, Qatar and New York, NY;**Medical Service/Infectious Diseases, VA Medical Center, Washington, DC; Department of Medicine, George Washington University Medical Center, Washington, DC;††Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, CA; David Geffen School of Medicine at UCLA, Los Angeles, CA;‡‡Infectious Diseases Section, Michael E. DeBakey VA Medical Center, Houston, TX; Infectious Diseases Section, Baylor College of Medicine, Houston, TX;§§VA Connecticut Healthcare System, West Haven, CT;‖‖Cell and Molecular Biology Department, John A. Burns School of Medicine, University of Hawaii- Manoa, Honolulu, HI;¶¶Philadelphia VA Medical Center, Philadelphia, PA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, VA;##Division of Infectious Diseases, Columbia University Medical Center, New York, NY;***Infectious Diseases Section, VA Greater Los Angeles Healthcare System, Los Angeles, CA; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA;†††Departments of Pathology and Laboratory Medicine and Biochemistry, College of Medicine, University of Vermont, Burlington, VT; and‡‡‡Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; Geriatric Research, Education, and Clinical Center, VA Tennessee Valley Healthcare System, Nashville, TN.
Objectives:
Obesity prevalence among people living with HIV (HIV+) is rising. HIV and obesity are proinflammatory states, but their combined effect on inflammation (measured by interleukin 6, IL-6), altered coagulation (D-dimer), and monocyte activation (soluble CD14, sCD14) is unknown. We hypothesized inflammation increases when obesity and HIV infection co-occur.
Methods:
The Veterans Aging Cohort Study survey cohort is a prospective, observational study of predominantly male HIV+ veterans and veterans uninfected with HIV; a subset provided blood samples. Inclusion criteria for this analysis were body mass index ≥ 18.5 kg/m and biomarker measurement. Dependent variables were IL-6, sCD14, and D-dimer quartiles. Obesity/HIV status was the primary predictor. Unadjusted and adjusted logistic regression models were constructed.
Results:
Data were analyzed for 1477 HIV+ and 823 uninfected participants. Unadjusted median IL-6 levels were significantly higher and sCD14 levels significantly lower in obese/HIV+ compared with nonobese/uninfected (P <0.01 for both). In adjusted analyses, the odds ratio for increased IL-6 in obese/HIV+ patients was 1.76 (95% confidence interval: 1.18 to 2.47) compared with nonobese/uninfected, and obesity/HIV+ remained associated with lower odds of elevated sCD14. We did not detect a synergistic association of co-occurring HIV and obesity on IL-6 or sCD14 elevation. D-dimer levels did not differ significantly between body mass index/HIV status groups.
Conclusions:
HIV-obesity comorbidity is associated with elevated IL-6, decreases in sCD14, and no significant difference in D-dimer. These findings are clinically significant, as previous studies associated these biomarkers with mortality. Future studies should assess whether other biomarkers show similar trends and potential mechanisms for unanticipated sCD14 and D-dimer findings.
Related Concept Videos
Obesity
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Psychoneuroimmunology: Diabetes and Cancer
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

